CATHERINE ROBERTS: Open Payments
NPI 1639429426 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,908 in 91 payments from 32 companies in 2025. Trend: 2023 $1,080 · 2024 $1,685 · 2025 $1,908
Food & beverage: $1,809Education: $99
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 11 | $274 |
| ABBVIE INC. | 6 | $208 |
| Janssen Biotech, Inc. | 10 | $163 |
| Merck Sharp & Dohme LLC | 8 | $160 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $128 |
| Incyte Corporation | 5 | $105 |
| Regeneron Healthcare Solutions, Inc. | 4 | $87 |
| Celgene Corporation | 4 | $83 |
| Genentech USA, Inc. | 3 | $60 |
| AstraZeneca Pharmaceuticals LP | 3 | $56 |
Products named: Nubeqa, REBLOZYL, KEYTRUDA, IMBRUVICA, Epkinly, LUTATHERA, RYBREVANT, PLUVICTO.
Industry payments across AL — which companies pay providers there.
